Dr. David Golden Discusses the Latest Anaphylaxis Guidelines and More episode artwork

EPISODE · Feb 3, 2025 · 31 MIN

Dr. David Golden Discusses the Latest Anaphylaxis Guidelines and More

from ImmunoCAST · host Thermo Fisher Scientific

Dr. David Golden is a member of the Joint Task Force on Practice Parameters and has directed research programs on insect allergy and anaphylaxis at Johns Hopkins for 30 years, publishing numerous research and review articles. In this episode we speak with Dr. Golden about the latest updates to the anaphylaxis practice parameters, emphasizing critical changes in recommendations around the role of epinephrine and more. Transitioning to stinging insect venom allergy, we discuss the effectiveness of venom immunotherapy, the role of testing with allergen components in tailoring treatment, and the impact of risk stratification on patient quality of life. Gain valuable insights into diagnostic strategies and management techniques that can enhance patient care and reduce fear associated with insect sting allergies. Episode resources and references available at https://www.thermofisher.com/phadia/us/en/resources/immunocast/doctor-david-golden-and-latest-anaphylaxis-guideline-updates.html?cid=0ct_3pc_05032024_9SGOV4

Episode metadata supplied by the publisher feed · Published Feb 3, 2025

Embed this episode

Ready to play

Dr. David Golden Discusses the Latest Anaphylaxis Guidelines and More

0:00 31:55

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of ImmunoCAST?

This episode is 31 minutes long.

When was this ImmunoCAST episode published?

This episode was published on February 3, 2025.

Can I download this ImmunoCAST episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!